Consensus statement on the benefit to the community of ESEMeD (European study of the epidemiology of mental disorders) survey data on depression and anxiety

Journal of Clinical Psychiatry

Volumn 68, Issue SUPPL. 2, 2007, Pages 42-48

  Nutt, David J ^a   Kessler, Ronald C ^b   Alonso, Jordi ^c   Benbow, Alastair ^d   Lecrubier, Yves ^e   Lépine, Jean Pierre ^f   Mechanic, David ^g   Tylee, André ^h  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d GLAXOSMITHKLINE   (United Kingdom)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HÔPITAL FERNAND WIDAL   (France)

^g RUTGERS UNIVERSITY   (United States)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ANXIETY; ANXIETY DISORDER; AWARENESS; CLINICAL STUDY; CONFERENCE PAPER; CONSENSUS; COUNSELING; DATA ANALYSIS; DEPRESSION; EUROPE; HEALTH SURVEY; HUMAN; INTERVIEW; MOOD DISORDER; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; PUBLIC HEALTH; SOCIAL SUPPORT; STIGMA;

ANXIETY DISORDERS; DATA COLLECTION; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; EDUCATION; EUROPE; HEALTH POLICY; HUMANS;

EID: 33847388521     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Sartorius N, Ustun TB, Costa e Silva JA, et al. An international study of psychological problems in primary care: preliminary report from the World Health Organization Collaborative Project on 'Psychological Problems in General Health Care.' Arch Gen Psychiatry 1993;50:819-824
2. Lepine JP, Gastpar M, Mendlewicz J, et al. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 1997;12:19-29
3. ESEMeD/MHEDEA 2000 Investigators. The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods. Int J Methods Psychiatr Res 2002;11:55-67
4. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Tenth Edition, Revised. Geneva, Switzerland: World Health Organization; 1992
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
7. Alonso J, Angermeyer MC, Bernert S, et al. Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:8-20
8. Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:21-27
9. Carta MG, Angst J. Epidemiological and clinical aspects of bipolar disorders: controversies or a common need to redefine the aims and methodological aspects of surveys. Clin Pract Epidemiol Ment Health 2005;1:4
10. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105
11. Alonso J, Lépine J-P. Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). J Clin Psychiatry 2007;68 (suppl 2):3-9
12. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19
13. Henderson S, Andrews G, Hall W. Australia's Mental Health: an overview of the General Population Survey. Aust N Z J Psychiatry 2000;34:197-205
14. Bijl R, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998;33:587-595
15. Alonso J, Angermeyer MC, Bernert S, et al. 12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:28-37
16. Ustun TB, Sartorius N, eds. Mental Illness in General Health Care: An International Study. Chichester, UK: John Wiley; 1995
17. Ormel J, Von Korff M, Ustun TB, et al. Common mental disorders and disability across cultures: results from the WHO Collaborative Study on Physiological Problems in General Health Care. JAMA 1994;272:1741-1748
18. Simon GE, Goldberg D, Tiemens BG, et al. Outcomes of recognized and unrecognized depression in an international primary care study. Gen Hosp Psychiatry 1999;21:97-105
19. Wittchen HU, Hofler M, Meister W. Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? Int Clin Psychopharmacol 2001;16:121-135
20. Furedi J, Rozsa S, Zambori J, et al. The role of symptoms in the recognition of mental health disorders in primary care. Psychosomatics 2003;44:402-406
21. Alonso J, Angermeyer MC, Bernert S, et al. Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:47-54
22. Bridges KW, Goldberg DP. Somatic presentation of DSM III psychiatric disorders in primary care. J Psychosom Res 1985;29:563-569
23. Kirmayer LJ, Robbins JM. Patients who somatize in primary care: a longitudinal study of cognitive and social characteristics. Psychol Med 1996;26:937-951
24. Angst J, Gamma A, Gastpar M, et al. Gender differences in depression: epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci 2002;252:201-209
25. Kessler D, Lloyd K, Lewis G, et al. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. BMJ 1999;318:436-439
26. Roy-Byrne PP, Craske MG, Stein MB, et al. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 2005;62:290-298
27. Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004;292:1969-1976
28. Alonso J, Angermeyer MC, Bernert S, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:55-64
29. Ormel J, Van Den Brink W, Koeter MWJ, et al. Recognition, management and outcome of psychological disorders in primary care: a naturalistic follow-up study. Psychol Med 1990;20:909-923
30. Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry 1999;56:897-904
31. Hays RD, Wells KB, Sherboume CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 1995;52:11-19
32. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-1442
33. Alonso J, Angermeyer MC, Bernert S, et al. Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:38-46
34. Park H, Sprince NL, Lewis MQ, et al. Risk factors for work-related injury among male farmers in Iowa: a prospective cohort study. J Occup Environ Med 2001;43:542-547
35. Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res 2003;12:22-33